N

National Health Scan
OTC:GEGR

Watchlist Manager
National Health Scan
OTC:GEGR
Watchlist
Price: 0.0007 USD Market Closed
Market Cap: $249.1

National Health Scan
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

National Health Scan
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
N
National Health Scan
OTC:GEGR
Cash & Cash Equivalents
759.1m
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
R
Roper Technologies Inc
F:ROP
Cash & Cash Equivalents
$382.9m
CAGR 3-Years
-31%
CAGR 5-Years
3%
CAGR 10-Years
-3%
General Electric Co
NYSE:GE
Cash & Cash Equivalents
$11B
CAGR 3-Years
-3%
CAGR 5-Years
-19%
CAGR 10-Years
-17%
3M Co
NYSE:MMM
Cash & Cash Equivalents
$3.7B
CAGR 3-Years
-1%
CAGR 5-Years
-4%
CAGR 10-Years
11%
Honeywell International Inc
NASDAQ:HON
Cash & Cash Equivalents
$12B
CAGR 3-Years
20%
CAGR 5-Years
0%
CAGR 10-Years
10%
B
Brookfield Business Corp
TSX:BBUC
Cash & Cash Equivalents
$710m
CAGR 3-Years
-1%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
No Stocks Found

National Health Scan
Glance View

The company is headquartered in Henderson, Nevada. The company went IPO on 2001-06-21.

GEGR Intrinsic Value
Not Available
N

See Also

What is National Health Scan's Cash & Cash Equivalents?
Cash & Cash Equivalents
759.1m

Based on the financial report for Dec 31, 2011, National Health Scan's Cash & Cash Equivalents amounts to 759.1m .

What is National Health Scan's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
18%

Over the last year, the Cash & Cash Equivalents growth was -4%. The average annual Cash & Cash Equivalents growth rates for National Health Scan have been 18% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett